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Background. Role of herbs in the management and control of diabetes has emerged fast over the years. We assessed the eﬃcacy
of Coccinia grandis (locally known as Ken, Kovakka) leaves as a hypoglycemic agent. Methods. Double-blind phase I clinical trial
was conducted at the general hospital and a private hospital in Matara in August 2009. All the participants were given a common
meal for dinner, and they maintained a 10-hour fasting period. Sixty-one healthy volunteers were given a meal containing 20g
of leaves of Coccinia grandis which was mixed with a measured amount of scraped coconut and table salt for breakfast, and other
61 were given the placebo meal which also contained scraped coconut and salt. Glucose tolerance test was performed blindly for
the two groups. Mixed factorial design analysis of variance and student’s t-test were applied. Results. Overall blood sugar levels
of the experimental group were also signiﬁcantly lower than those of the control group (F(1,117) 5.56, P<0.05). Increase in the
blood sugar levels from fasting to one hour (F(1,117) 6.77, P<0.05) and two hours (F(1,117) 5.28, P<0.05) postprandially was
statisticallysigniﬁcantforparticipantswhowereinthecontrolgroupthanthoseofintheexperimentalgroup.Themeandiﬀerence
of postprandial blood sugar levels (mg/dL) after one hour (20.2, 95% conﬁdence interval, 4.81 to 35.5) and two hours (11.46, 95%
conﬁdence interval; 1.03 to 21.9) was statistically signiﬁcant between the two groups. Conclusions. Coccinia grandis has a blood
sugar lowering eﬀect. However further studies are needed to validate our ﬁndings.
1.Introduction
It is a well-known fact that throughout the world about 180
million people suﬀer from diabetes and its dreadful com-
plications [1]. Therefore, new concepts in the management
of diabetes have aroused a curiosity among doctors as well
as among the patients throughout the world. Role of herbs
in the management and control of diabetes has emerged
fast over the years with the discovery of hypoglycemic eﬀect
of Bitter Melon (Mormodica charantia)[ 2, 3]. Currently
the extracts of these plants are used as adjuvant therapy
with other medications in many eastern countries for the
treatment of diabetes.
Ken (Coccinia grandis) has been used in ayurvedic
medicine in Sri Lanka and India to treat diabetes from
ancient times [4]. Coccinia grandis is also known by the
synonyms Coccinia indica and Coccinia cordifolia [5]. Young
leaves and long slender stem tops of the plant are cooked
and eaten as a potherb or added to soups. Young and tender
green fruits are used either as raw salads or cooked and
added to curries. Our attention was focused on this herb,
and further investigations revealed that, despite the absence
of any scientiﬁc evidence, Sri Lankans are well convinced
about its hypoglycemic eﬀects. As no publications were
found in the literature review regarding the hypoglycemic
eﬀect of this herb on healthy volunteers, this study was
designed to assess the eﬃcacy of leaves of Coccinia grandis as
a hypoglycaemic agent in healthy individuals and to identify
common short-term adverse eﬀects. However there were two2 Experimental Diabetes Research
publications regarding hypoglycemic eﬀect of this herb on
diabetic patients [6, 7].
2.MaterialsandMethods
This double-blind phase I clinical trial was conducted at
the general hospital and a private hospital in Matara using
122 healthy volunteers in August 2009. The volunteers were
of 18–55 age range who were nonsmokers and were not
on regular medication or alcohol. Pregnant women were
excluded from the study. Procedure was explained to each
individual, and informed written consent was obtained to
participate in the trial. Demographic information was taken
on the previous day, and all of them were given a common
meal for dinner and 10 hours fasting was maintained.
Randomization was performed by tossing a coin in each
centre to select the two groups.
Eachtestmealcontained20gofleavesofCocciniagrandis
which were mixed with a measured amount of scraped
coconut and table salt. Each sample was prepared in a
similar manner. Twenty grams of leaves of Erythrina indica
(locally known as Erabadu) were mixed with a measured
amount of scraped coconut and table salt and given as
placebo. Erythrina indica is a kind of edible leaves commonly
used by Sri Lankans as a salad or tempered leaves. We
decided to use Erythrina indica because of its similarity
in color and taste to of Coccinia grandis, and it was not
known to cause any adverse eﬀects such as hypoglycemia.
All participants were asked to consume the green leaves
completely under observation. Sixty-one participants were
given a meal containing the testing substance for breakfast,
and other 61 were given the placebo meal. The participants
were unaware of the type of the meal they received. All of
them were given 75 grams of glucose in 300mL of water
and asked to drink it within 20 minutes under observation.
Venousbloodwasdrawnafteronehourandtwohours(2mL
in each occasion) as in oral glucose tolerance test (OGTT)
by three trained nurses. Blood samples were analyzed at
the laboratory of a private hospital. Medical Laboratory
Technologist (MLT) who analyzed the blood sugar level was
unaware of the group of allocation of the two treatment
regimes. A self-administered questionnaire was used for
assessing side eﬀects.
Data was analyzed using SPSS.16. Student’s t-test was
applied for the blood sugar levels between the two groups
before and after the intervention. As this study was involving
data collection over the time, a mixed factorial design
analysis of variance was applied. Two-tailed P value of less
than 0.05 was considered as statistically signiﬁcant. The
Ethics Review Committee of the Faculty of Medicine, Uni-
versity of Kelaniya, Sri Lanka granted the ethical approval.
3. Results
While sixty-one participants of the total (50%) received
Coccinia grandis (the testing substance), the rest of the
participants (61) received control (Erythrina indica). Among
the experimental group 31 (50.8%) were males but only
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Figure 1: Mean blood sugar levels for experimental and control
groups before and after intervention.
17 (28%) were males in the control group. The mean age
of experimental group was 33 (SD ± 11) years, and the
corresponding ﬁgure was 37 (SD ± 12) years for the control
group. Postprandial blood sugar levels after one hour were
found to be missing in one participant from each group, and
also sugar levels after two hours were found to be missing in
one participant from the control group as well as from two
participants of the experimental group.
As shown in the Figure 1, postprandial blood sugar levels
afteronehourandtwohourswerehigherinbothexperimen-
tal and control groups. In contrast, the participants in the
experimental group showed lower postprandial blood sugar
levels after one hour and two hours, respectively. A mixed
design analysis of variance showed that this interaction
between intervention and postprandial blood sugar levels
was signiﬁcant (F(1.48,173.7) 5.25, P<0.001, partial eta
squared = 0.043). An interaction contrast showed that the
increase in blood sugar levels from fasting to one hour
postprandial was statistically signiﬁcant for participants who
were in the control group than for those in the experimental
group (F(1,117) 6.77, P<0.05, partial eta squared =
0.055). A further contrast revealed that the increase in
blood sugar levels from fasting to two hours postprandially
was statistically signiﬁcant for participants who were in the
controlgroupthanintheexperimentalgroup(F(1,117)5.28,
P<0.05, partial eta squared = 0.043). Overall blood sugar
levels in the experimental group were also signiﬁcantly lower
than in the control group (F(1,117) 5.56, P<0.05, partial eta
squared=0.045).AsshowninTable 1,thediﬀerencebetweenExperimental Diabetes Research 3
Table 1: Means and standard deviations of blood sugar levels for experimental and control groups before and after intervention.
Blood sugar (mg/dL)
Groups Mean SD Mean diﬀerence 95% Conﬁdence interval P value
Fasting
Experimental (n = 61) 88.9 9.7
Control (n = 61) 91.5 17.6 2.57 −2.49 to 7.64 0.31
One hour postprandially
Experimental (n = 60) 101.3 34.7
Control (n = 60) 120.8 49.0 20.2 4.81 to 35.5 0.01
Two hours postprandially
Experimental (n = 59) 90.3 19.7
Control (n = 60) 101.8 35.5 11.46 1.03 to 21.9 0.03
the fasting blood sugar levels in the two groups were not
statistically signiﬁcant. In contrast, the postprandial blood
sugar levels after one hour and two hours were statistically
signiﬁcant between the experimental and control groups.
Nausea, headache, and drowsiness were experienced
by 1 (1.7%), 3 (5%), and 17 (29%) participants in the
experimental group, respectively, and 2 (3.3%), 3 (5%), and
25(41.6%)inthecontrolgroup.Sweating,tremor,pounding
heartbeat, pallor, or cold extremities were not reported from
any participant.
4. Discussion
Our study showed that overall blood sugar levels in the
experimental group were signiﬁcantly lower than those in
the control group. The study also showed that the increase
in blood sugar levels from fasting to one hour postprandially
was statistically signiﬁcant for participants who were in the
control group than for those in the experimental group.
The same statistical signiﬁcance was observed in the two-
hour postprandial blood sugar levels. Further, the diﬀerence
between the blood sugar levels at one hour postprandially
(19.5mg/dL)wasmorethanthatattwohourspostprandially
(11.5mg/dL). Our ﬁndings indicated that raw Ken (Coc-
cinia grandis) leaves lowered the postprandial blood sugar
levels proving the herb improving the glucose tolerance.
Mechanism of action by which the glucose tolerance was
improved is to be studied by further research. This can
happenatvariousstepswhichresultsintheincreasedglucose
tolerance. Reduction of sugar absorption from the gut,
increased insulin production from the pancreas, reduction
of release of glucose from the liver, increasing glucose uptake
by fat and muscle cells are probable mechanisms which may
be involved. Some studies have suggested that suppression of
glucose-6-phosphatase [8] increases the activity of glycogen
syntheses [9], and it is partly responsible for this.
We decided to use Erythrina indica as a placebo because
it has no hypoglycemic eﬀect on humans [10, 11]. Even
if it has any hypoglycemic eﬀects, it does not interfere
with our results, because we have shown a strong statistical
signiﬁcanceintheexperimentalgroupusingCocciniagrandis
on its hypoglycemic eﬀects.
We selected 122 healthy volunteers dividing them into
two groups which were comparable in terms of age and sex
minimizing selection bias. Preparation of the test and the
placebo substance and the analysis of ﬁnal blood sugar levels
were done strictly in a double-blind manner.
In conclusion, Coccinia grandis has a blood sugar low-
ering eﬀect. Further studies are needed to extract the active
component of the herb, explore the mechanism of action,
and determine the dosage of the drug and the side eﬀects.
However following points can be mentioned as the
limitations of our study. That is, we have not measured
the BMI, exact concentration of the active component of
Coccinia grandis in the study population. We also have not
explained the reason for the signiﬁcant diﬀerence of the sex
between two groups.
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